Literature DB >> 27256459

Investigation of the expression of irisin and some cachectic factors in mice with experimentally induced gastric cancer.

Diler Us Altay1, E Edip Keha2, Serap Ozer Yaman2, Imran Ince2, Ahmet Alver2, Bahattin Erdogan3, Sinan Canpolat4, Umit Cobanoglu5, Ahmet Mentese2.   

Abstract

BACKGROUND: The purpose of this study was to determine whether irisin is secreted by gastric tumor cells experimentally induced in mice, and also if it has any effect on cancer cachexia. DESIGN AND METHODS: 12 out of 60 BALB/c mice were used as a control group, while N-nitroso-N-methylurea (MNU) was administered orally to the remaining 48. After 150 days, the surviving mice were sacrificed by decapitation, blood and stomach, skeletal muscle, brown and white adipose tissue specimens were collected. Following histopathological evaluation of the stomach tissues, it was decided to create four groups, one control group and three consisting of mice administered MNU, no cancer, pre-cancer and cancer. Gene expression analyses of fibronectin type III domain containing protein 5 (FNDC5) and some cachexia-related proteins were performed in tissue samples, while levels of irisin, and various inflammatory and tumor markers together with cachectic factors were determined in serum samples.
RESULTS: The levels of inflammatory, tumor markers and cachectic factors in serum samples were significantly higher in the cancer group compared with the control group. No expression of FNDC5 or zinc-α-2 glycoprotein, a cachectic factor, was observed in gastric tissues from the control and MNU groups, whereas significantly increased FNDC5 expression was determined in the both white and brown adipose tissues from the cancer group.
CONCLUSION: Increased FNDC5 expression in white and brown adipose tissues may have a cachectic effect in mice with induced cancer. However, it is not possible to explain the mechanism of the relationship between irisin and gastric cancer development on the basis of the results of this study.
© The Author 2016. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27256459     DOI: 10.1093/qjmed/hcw074

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  12 in total

Review 1.  The impact of exercise training on adipose tissue remodelling in cancer cachexia.

Authors:  Rita Ferreira; Rita Nogueira-Ferreira; Rui Vitorino; Lúcio Lara Santos; Daniel Moreira-Gonçalves
Journal:  Porto Biomed J       Date:  2017-06-11

2.  Significance of Irisin (FNDC5) Expression in Colorectal Cancer.

Authors:  Slawomir Wozniak; Katarzyna Nowinska; Mariusz Chabowski; Piotr Dziegiel
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

Review 3.  Role of myokines and osteokines in cancer cachexia.

Authors:  Fabrizio Pin; Lynda F Bonewald; Andrea Bonetto
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-25

4.  Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway.

Authors:  Gang Kong; Yunpeng Jiang; Xiujiang Sun; Zhilin Cao; Guodong Zhang; Zhongyuan Zhao; Yong Zhao; Qian Yu; Gong Cheng
Journal:  Oncol Rep       Date:  2017-09-20       Impact factor: 3.906

5.  Can the Irisin be a Biomarker for Prostate Cancer? A Case Control Study.

Authors:  Rahmi Aslan; Hamit Hakan Alp; Recep Eryılmaz; Zubeyir Huyut; Mehmet Sevim; Şeyhmuz Araz; Kasim Ertas; Kerem Taken
Journal:  Asian Pac J Cancer Prev       Date:  2020-02-01

6.  The Diagnostic Value of FNDC5/Irisin in Renal Cell Cancer.

Authors:  Diler Us Altay; Esref Edip Keha; Ersagun Karagüzel; Ahmet Menteşe; Serap Ozer Yaman; Ahmet Alver
Journal:  Int Braz J Urol       Date:  2018 Jul-Aug       Impact factor: 1.541

Review 7.  Exercise-Induced Irisin, the Fat Browning Myokine, as a Potential Anticancer Agent.

Authors:  George-Emmanuel Maalouf; Diala El Khoury
Journal:  J Obes       Date:  2019-04-01

8.  A newly identified myokine: irisin, and its relationship with chronic spontaneous urticaria and inflammation.

Authors:  Diler Us Altay; Sevda Onder; Fatma Etgu; Abdullah Uner; Tevfik Noyan
Journal:  Arch Dermatol Res       Date:  2022-08-10       Impact factor: 3.033

Review 9.  Review of Research on the Role of Irisin in Tumors.

Authors:  Zengyin Chen; Guangjun Shi; Deguo Zhang; Xueying Tan; Nan Tang; Fei Huang
Journal:  Onco Targets Ther       Date:  2020-05-19       Impact factor: 4.147

10.  Circulating Irisin Levels and Redox Status Markers in Patients with Gastric Cancer: A Case-Control Study.

Authors:  Shabnam Shahidi; Jalal Hejazi; Minoosh Moghimi; Soheila Borji; Saeed Zabihian; Mojtaba Fathi
Journal:  Asian Pac J Cancer Prev       Date:  2020-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.